Cardiovascular

Rosuvast

Rosuvastatin

Film-coated tablets Made in Medjez El Bab GMP-certified site
INN
Rosuvastatin
Dosage form
Film-coated tablets
Therapeutic area
Cardiovascular
Indications
Treatment of hypercholesterolaemia: adults, adolescents and children aged 6 years or older with primary hypercholesterolaemia (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb), as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolaemia, as an adjunct to diet and other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.

Presentations

PresentationStrengthPack size
Rosuvast5mgBottle of 30
Rosuvast10mgBottle of 30
Rosuvast20mgBottle of 30

Information intended for healthcare professionals. Prescription-only medicine in accordance with current regulations: read the package leaflet carefully. Translation provided for information only. Only the package leaflet approved in the country of marketing is authoritative.